CD4 and adult T-cell leukemia/lymphoma: It primarily targets CD4+ T-cells, causing severe diseases such as adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [87,88].